Rebamipide/Benzydamine Hydrochloride

雷巴米特/盐酸苄达明

Report date: 2025/07/25 10:36:08

Base Information

Drug NameRebamipide/Benzydamine Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsStomatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsYes RebamipideBenzydamine Hydrochloride
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCairo University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCairo University
Active IndicationsN/A
Inactive IndicationsStomatitis

Other Information

ATC CodeN/A
Related LinksN/A